Correlation Between Pharma Reaserch and Medy Tox
Can any of the company-specific risk be diversified away by investing in both Pharma Reaserch and Medy Tox at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharma Reaserch and Medy Tox into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharma Reaserch Prod and Medy Tox, you can compare the effects of market volatilities on Pharma Reaserch and Medy Tox and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharma Reaserch with a short position of Medy Tox. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharma Reaserch and Medy Tox.
Diversification Opportunities for Pharma Reaserch and Medy Tox
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pharma and Medy is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Pharma Reaserch Prod and Medy Tox in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medy Tox and Pharma Reaserch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharma Reaserch Prod are associated (or correlated) with Medy Tox. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medy Tox has no effect on the direction of Pharma Reaserch i.e., Pharma Reaserch and Medy Tox go up and down completely randomly.
Pair Corralation between Pharma Reaserch and Medy Tox
Assuming the 90 days trading horizon Pharma Reaserch Prod is expected to generate 0.89 times more return on investment than Medy Tox. However, Pharma Reaserch Prod is 1.12 times less risky than Medy Tox. It trades about 0.09 of its potential returns per unit of risk. Medy Tox is currently generating about 0.01 per unit of risk. If you would invest 7,682,892 in Pharma Reaserch Prod on October 13, 2024 and sell it today you would earn a total of 17,417,108 from holding Pharma Reaserch Prod or generate 226.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharma Reaserch Prod vs. Medy Tox
Performance |
| Timeline |
| Pharma Reaserch Prod |
| Medy Tox |
Pharma Reaserch and Medy Tox Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharma Reaserch and Medy Tox
The main advantage of trading using opposite Pharma Reaserch and Medy Tox positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharma Reaserch position performs unexpectedly, Medy Tox can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medy Tox will offset losses from the drop in Medy Tox's long position.| Pharma Reaserch vs. Medy Tox | Pharma Reaserch vs. Seegene | Pharma Reaserch vs. ALTEOGEN | Pharma Reaserch vs. ABL Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |